Close Menu
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
What's Hot

Unique molecule may lead to smaller, more efficient computers

May 9, 2025

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
  • News
  • Medical
  • Technology
  • Nanomaterials
  • Research
  • Blog
    • Nasiol.com
  • Contact
    • Tech7685@gmail.com
Facebook X (Twitter) Instagram
Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily Nanotech – Nanomaterials | Medical | Research | News Stories Updated Daily
Home»Medical»UQ opens new facility for personalized mRNA cancer vaccine development
Medical

UQ opens new facility for personalized mRNA cancer vaccine development

July 26, 2024No Comments3 Mins Read
Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
UQ opens new facility for personalized mRNA cancer vaccine development
Share
Facebook Twitter LinkedIn Pinterest Telegram Email

A new facility at The University of Queensland is set to provide Australian researchers with cancer vaccines tailored to individual patients.

The lab at UQ’s Australian Institute for Bioengineering and Nanotechnology (AIBN) will bring together the equipment and expertise to enable the design, manufacture and delivery of new mRNA cancer vaccines.

Backed by a $3.3 million grant from the Medical Research Future Fund’s (MRFF) National Critical Research Infrastructure program, the new hub will provide the local research community with vaccines that match the specific treatment needs of each patient.

Dr. Seth Cheetham, Deputy Director of AIBN’s BASE facility, said it could transform cancer treatment.

Personalized mRNA cancer vaccines are now being used to train the body’s immune system to recognize and eradicate cancer cells.

Despite the huge potential, Australian researchers haven’t had the necessary infrastructure to build these vaccines, leading to a critical gap in the local drug development pipeline.

This lab changes that, with a leading team of investigators in a purpose-built space, working with local industry and academics to progress a range of high-quality mRNA cancer vaccine candidates from design through to preclinical evaluation, with the aim of enabling future clinical trials.”

Dr. Seth Cheetham, Deputy Director of AIBN’s BASE facility

The mRNA cancer vaccine hub is expected to be operating in BASE by late 2024.

BASE is already recognised as Australia’s leading provider of mRNA for research and pilot studies, and since its launch in 2021 has provided academic and industry partners with more than 300 experimental grade vaccines.

See also  Soft X-ray microscope captures living mammalian cells

“As well as the potential impacts on patient health, mRNA cancer vaccines represent a $7 billion opportunity over the next decade,” Dr Cheetham said.

“This is a rapidly expanding industry encompassing researchers, biotech start-ups and multinational pharmaceuticals, and AIBN and BASE will now be at the centre of a range of promising new treatment options.”

The new lab was one of 4 UQ projects funded in the latest MRFF grant round, adding to the $6.6 million funding awarded to BASE in 2023 to boost clinical mRNA production capabilities.

AIBN director Professor Alan Rowan said the hub would complement Australia’s existing research strengths in oncology and affirm AIBN as a therapeutics and personalised medicine pipeline.

“Governments and society want sustainable innovation that enables high quality research and delivers translatable outcomes,” Professor Rowan said.

“The mRNA cancer vaccine hub is the latest example of how AIBN combines world class infrastructure and technical expertise to bridge the gap between research and clinical development.”

The 5-year program will also bring together partner investigators from UQ, QIMR-Berghofer, Mater Research, Garvan Institute of Medical Research and the Queensland Children’s Hospital.

Source:

The University of Queensland

Source link

cancer development facility mRNA opens personalized vaccine
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

In What Ways Can Nanosensors Be Used to Detect Cancer?

April 22, 2025

AI combined with nanotech can detect oral cancer earlier

April 21, 2025

Engineers develop a way to mass manufacture nanoparticles that deliver cancer drugs directly to tumors

April 15, 2025

Magnetic nanoparticles transport drugs deep into tumors to slow cancer growth

March 27, 2025

‘Nanosnag’ virus detection technique could streamline vaccine production quality checks

March 19, 2025

Nanoparticle immune therapy shows potential to halt pancreatic cancer spread

March 16, 2025

Comments are closed.

Top Articles
News

Nanoelectronic Devices Uses 100x Less Energy

News

Hummingbird beak points the way to future micro machine design

News

How black silicon, a prized material used in solar cells, gets its dark, rough edge

Editors Picks

Unique molecule may lead to smaller, more efficient computers

May 9, 2025

Depositing quantum dots on corrugated chips improves photodetector capabilities

May 8, 2025

Ultrasonic nanocrystal surface modification restores stainless steel’s corrosion resistance

May 7, 2025

Structure dictates effectiveness and safety in nanomedicine, driving therapeutic innovation, say scientists

May 7, 2025
About Us
About Us

Your go-to source for the latest nanotechnology breakthroughs. Explore innovations, applications, and implications shaping the future at the molecular level. Stay informed, embrace the nano-revolution.

We're accepting new partnerships right now.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Nanoscale trilayer exhibits ultrafast charge transfer in semiconductor materials

July 28, 2024

Hand-held biosensor detects breast cancer biomarkers from saliva

February 15, 2024

Nanowire-based capture of micro-ribonucleic acids

November 27, 2024

Subscribe to Updates

Get the latest creative Nano Tech news from Elnano.com

© 2025 Elnano.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.

Cleantalk Pixel